Delivery Order SPE2DE24D0013-SPE2D626F3071
- Not listed
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,080.00 by the Defense Department's Medical Supply Chain on August 12, 2025. This firm fixed-price contract, designated as 4569079038 for XPCOV2/FLU/RSV-10, is scheduled for ultimate completion by August 19, 2025, with performance taking place in Sunnyvale, California. The contract carries no set-aside designation and represents a delivery order likely drawn from...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,096.80 firm fixed-price delivery order by the Medical Supply Chain (Defense) on June 30, 2025, with an ultimate completion date of July 15, 2025. The contract, designated as XPCOV2/FLU/RSV-10, carries no set-aside designation and specifies performance in Sunnyvale, California. This delivery order pertains to molecular diagnostic testing capabilities for COVID-19, influenza, and respiratory...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $40,800 by the Defense Department's Medical Supply Chain on August 14, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing solutions with an ultimate completion date of August 21, 2025. This award includes no set-aside designation and represents work to be...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F3071Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $8,160 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus. The award carries no set-aside designation and represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic solutions to the Department of Defense and other federal healthcare agencies. The performance location is established in Sunnyvale, California. This delivery order falls within the broader context of Cepheid's extensive federal contracting history, particularly its established partnerships with the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. Cepheid has demonstrated substantial capability in providing GeneXpert diagnostic platform solutions and associated molecular testing capabilities across multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The modest contract value of $8,160 reflects a routine procurement action under the Medical Supply Chain's established vendor relationships for infectious disease diagnostic materials, supporting federal healthcare operations and rapid molecular diagnostic testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 10/20/25 |